Clinical Trials in Cancer : Insights for Oncology Nurses

Image

Global Journal of Interdisciplinary Social Sciences (GJISS) is a peer-reviewed International research journal published online. This journal offers a platform for scholars, academicians, professionals and students, to contribute interdisciplinary research from across the fields within the social sciences including, but not limited to : Anthropology, Arts & culture, Communication studies, Criminology, Cross-cultural studies in Demography, Economics, Education, English, Ethics, Geography, History, International relations, Law, Library science, Linguistics, Literature, Media studies, Political science, Psychology, Public administration, Sociology & Philosophy. The journal offers a global platform for the academia to elevate their scholarly image internationally as it reaches a wide spectrum of readers globally.

For many years, oncology research has set the bar for how to apply research findings in practise.The increased paediatric oncology survival rates, which are the consequence of oncology research, are a good example.The overall childhood cancer 5-year survival rate was only 58% in the middle of the 1970s; currently, it is 5 years or longer.The increase in paediatric cancer survival rates is entirely due to clinical research and the availability of trials to the paediatric population.

The sorts of clinical trials and studies, their phases, the involvement of the US Food and Drug Administration (FDA), and their significance for oncology nurse research will all be covered in this article.

Clinical research's overarching objective is to establish the safety and efficacy of a treatment or intervention in order to advance knowledge that may be applied to better patient treatments.

A clinical trial, according to the National Institutes of Health, is a project in which one or more human participants are prospectively assigned to one or more interventions, typically with a placebo or other control, to evaluate the impact of those interventions on behavioural or biomedical outcomes related to health.

Clinical research's overarching objective is to establish the safety and efficacy of a treatment or intervention in order to advance knowledge that may be applied to better patient treatments.

A clinical trial, according to the National Institutes of Health, is a project in which one or more human participants are prospectively assigned to one or more interventions, typically with a placebo or other control, to evaluate the impact of those interventions on behavioural or biomedical outcomes related to health.

To receive FDA approval for usage in patients, new oncology medications must undergo extensive research over many years in the US.

We'll talk about the FDA's mandate, regulatory framework, and medication research and approval process in this part.

The FDA's goal is to safeguard the public's health by guaranteeing the effectiveness, security, and safety of human and veterinary pharmaceuticals, biological products, and medical equipment, as well as the security of our country's food supply, cosmetics, and radiation-emitting items.

The FDA's goal is to safeguard the public's health by guaranteeing the effectiveness, security, and safety of human and veterinary pharmaceuticals, biological products, and medical equipment, as well as the security of our country's food supply, cosmetics, and radiation-emitting items.